RegenETP Inc. (RGTPQ)
OTCMKTS: RGTPQ · Delayed Price · USD
0.185
-0.031 (-14.26%)
Jul 24, 2024, 4:00 PM EDT - Market closed
RegenETP Employees
As of December 31, 2022, RegenETP had 44 total employees, including 42 full-time and 2 part-time employees. The number of employees decreased by 25 or -36.23% compared to the previous year.
Employees
44
Change (1Y)
-25
Growth (1Y)
-36.23%
Revenue / Employee
$18,500
Profits / Employee
-$178,023
Market Cap
1.40M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
RGTPQ News
- 1 year ago - PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company - PRNewsWire
- 1 year ago - PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update - PRNewsWire
- 1 year ago - PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company - PRNewsWire
- 2 years ago - PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022 - PRNewsWire
- 2 years ago - PolarityTE Announces Resignation of Jeff Dyer from its Board of Directors - PRNewsWire
- 2 years ago - PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update - PRNewsWire
- 2 years ago - PolarityTE to Report Q2 2022 Financial Results on August 11, 2022 - PRNewsWire
- 2 years ago - PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules - PRNewsWire